Sato H, Hirata J, Kuroda N, Shiraki H, Maeda Y, Okochi K
Clinical Laboratory, Kyushu University Hospital, Fukuoka, Japan.
J Virol. 1991 Oct;65(10):5485-90. doi: 10.1128/JVI.65.10.5485-5490.1991.
We identified and mapped the regions responsible for neutralization in the human parvovirus B19 structural protein by using region-specific human antibodies derived from seropositive blood donors. The region-specific antibodies were purified by using affinity columns coupled with synthetic peptides of the hydrophilic regions including the beta-turn structure deduced by the predicted secondary structure of VP2. Fifteen highly specific antibodies against the synthetic peptides were obtained. Ten of them were able to precipitate the radiolabeled virus. Six of them proved to be able to protect the colony-forming unit erythroid cells in human bone marrow cell cultures from injury by the virus. The sequences recognized by the six neutralizing antibodies were sites corresponding to amino acids 253 to 272, 309 to 330, 325 to 346, 359 to 382, 449 to 468, and 491 to 515 from the amino-terminal portion of VP2. These observations suggest that the neutralizing epitopes were distributed in the region from amino acid 253 in the amino-terminal portion of VP2 to the carboxyl terminus of VP2.
我们通过使用来自血清反应阳性献血者的区域特异性人抗体,鉴定并绘制了人细小病毒B19结构蛋白中负责中和作用的区域。通过使用与亲水区合成肽偶联的亲和柱纯化区域特异性抗体,所述亲水区包括由VP2预测二级结构推导的β-转角结构。获得了15种针对合成肽的高特异性抗体。其中10种能够沉淀放射性标记病毒。其中6种被证明能够保护人骨髓细胞培养物中的集落形成单位红细胞免受病毒损伤。这6种中和抗体识别的序列是与VP2氨基末端部分的氨基酸253至272、309至330、325至346、359至382、449至468以及491至515相对应的位点。这些观察结果表明,中和表位分布在从VP2氨基末端部分的氨基酸253到VP2羧基末端的区域。